Fresenius SE & Co KGaA (FRE.DE)
-XETRA 96.49 
1.11(1.14%) May 17, 11:35AM EDT
| Prev Close: | 97.60 |
|---|
| Open: | 97.73 |
|---|
| Bid: | 96.25 |
|---|
| Ask: | 96.35 |
|---|
| 1y Target Est: | N/A |
|---|
| Beta: | N/A |
|---|
| Next Earnings Date: | N/A |
|---|
| Day's Range: | 96.12 - 97.73 |
|---|
| 52wk Range: | 73.00 - 99.91 |
|---|
| Volume: | 553,975 |
|---|
| Avg Vol (3m): | 419,680 |
|---|
| Market Cap: | 17.20B |
|---|
| P/E (ttm): | 18.81 |
|---|
| EPS (ttm): | 5.13 |
|---|
| Div & Yield: | N/A (N/A) |
|---|
Quotes delayed, except where indicated otherwise. Currency in EUR.
Headlines
- Fresenius eyes more hospital deals in Germanyat Reuters(Fri, May 17)
- German stocks - Factors to watch on May 17at Reuters(Fri, May 17)
- Fresenius SE eyes small and mid-sized acquisition targets-paperat Reuters(Sat, May 11)
- Rhoen says shareholder to challenge 90 pct acceptance hurdleat Reuters(Fri, May 10)
- Q1 2013 Fresenius SE & Co KGaA Earnings Release (IFRS) - Time Not SuppliedCCBN(Wed, May 8)
- Q1 2013 Fresenius SE & Co KGaA Earnings Release (US GAAP) - Time Not SuppliedCCBN(Mon, May 6)
- Q1 2013 Fresenius SE & Co KGaA Earnings Release - Time Not SuppliedCCBN(Tue, Apr 30)
- German Stocks Advance on Central Bank Stimulus Optimismat Bloomberg(Tue, Apr 30)
- UPDATE 1-Fresenius Medical profit below consensus on U.S. costsat Reuters(Tue, Apr 30)
- BRIEF-Fresenius shares down 1.8 pct after Q1 resultsat Reuters(Tue, Apr 30)
- Fresenius SE Profit Rises 12% on Hospital and Intravenous Unitsat Bloomberg(Tue, Apr 30)
- Fresenius earnings below consensus on healthcare cutsat Reuters(Tue, Apr 30)
- Fresenius Medical Q1 net income down on U.S. healthcare cutsat Reuters(Tue, Apr 30)
- Rhoen-Klinikum Q1 core profit down 8.4 pct on higher wagesat Reuters(Thu, Apr 25)
- German stocks - Factors to watch on April 16at Reuters(Tue, Apr 16)
Reports
- No Reports available for FRE.DE at this time.
Key Statistics
| Forward P/E (1 yr): | N/A |
|---|
| P/S (ttm): | 0.88 |
|---|
| Ex-Dividend Date: | N/A |
|---|
Analysts
| Annual EPS Est
()
: | N/A |
|---|
| Quarterly EPS Est
()
: | N/A |
|---|
| Mean Recommendation*: | N/A |
|---|
| PEG Ratio (5 yr expected): | N/A |
|---|
Business Summary
Fresenius SE & Co. KGaA provides products and services for dialysis, hospital, and outpatient medical care worldwide. Its Fresenius Medical Care segment provides products and services for the treatment of patients with chronic kidney failure.
View More